相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systemic Analysis of the Prognosis-Related RNA Alternative Splicing Signals in Melanoma
Dan Xue et al.
MEDICAL SCIENCE MONITOR (2020)
Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma
Qi Wan et al.
GENES (2020)
Identification of prognostic splicing factors and exploration of their potential regulatory mechanisms in pancreatic adenocarcinoma
Min-hua Rong et al.
PEERJ (2020)
Modulator-Dependent RBPs Changes Alternative Splicing Outcomes in Kidney Cancer
Yang Wang et al.
FRONTIERS IN GENETICS (2020)
Survival-associated alternative splicing signatures in esophageal carcinoma
Shuangshuang Mao et al.
CARCINOGENESIS (2019)
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia
Eric Wang et al.
CANCER CELL (2019)
The molecular clock in the skin, its functionality, and how it is disrupted in cutaneous melanoma: a new pharmacological target?
Leonardo Vinicius Monteiro de Assis et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Pan-cancer analysis of clinical relevance of alternative splicing events in 31 human cancers
Yangjun Zhang et al.
ONCOGENE (2019)
Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma
Dong Zhang et al.
ONCOLOGY REPORTS (2019)
Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution
Jernej Ule et al.
MOLECULAR CELL (2019)
Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
Tong Meng et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
The role of alternative splicing in cancer drug resistance
Zahava Siegfried et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis
Pourya Arbab Jafari et al.
HEMATOLOGY (2018)
Cutaneous melanoma: From pathogenesis to therapy (Review)
Giulia C. Leonardi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Emerging Biomarkers in Cutaneous Melanoma
Anna Eisenstein et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Alternative splicing in cancers: From aberrant regulation to new therapeutics
Xiaowei Song et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth
Yuhan Chen et al.
NATURE COMMUNICATIONS (2018)
Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Laura M. Urbanski et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2018)
Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center
Kenjiro Namikawa et al.
CANCER MEDICINE (2018)
Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes
Naoki Shingai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Aberrant RNA Splicing in Cancer and Drug Resistance
Bi-Dar Wang et al.
CANCERS (2018)
JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component
Xujun Liu et al.
MOLECULAR CANCER (2017)
TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing
Tieju Liu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
The Functional Impact of Alternative Splicing in Cancer
Hector Climente-Gonzalez et al.
CELL REPORTS (2017)
The role of alternative splicing in cancer
Babita Singh et al.
TRANSCRIPTION-AUSTIN (2017)
Tumor Infiltrating Lymphocytes (TILs) May be Only an Independent Predictor of Nodal Involvement but not for Recurrence and Survival in Cutaneous Melanoma Patients
Faruk Tas et al.
CANCER INVESTIGATION (2017)
Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690
Mohammed Kashani-Sabet et al.
CLINICAL CANCER RESEARCH (2017)
Roles of alternative splicing in modulating transcriptional regulation
Jin Li et al.
BMC SYSTEMS BIOLOGY (2017)
TCGASpliceSeq a compendium of alternative mRNA splicing in cancer.
Michael Ryan et al.
NUCLEIC ACIDS RESEARCH (2016)
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
A. Sveen et al.
ONCOGENE (2016)
Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks
Endre Sebestyen et al.
GENOME RESEARCH (2016)
The hnRNP family: insights into their role in health and disease
Thomas Geuens et al.
HUMAN GENETICS (2016)
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation
P. Zhang et al.
ONCOGENE (2016)
Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy
Maayan Salton et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
Samar Alsafadi et al.
NATURE COMMUNICATIONS (2016)
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
Hsin-An Hou et al.
ONCOTARGET (2016)
Increased Set1 binding at the promoter induces aberrant epigenetic alterations and up-regulates cyclic adenosine 5′-monophosphate response element modulator alpha in systemic lupus erythematosus
Qing Zhang et al.
CLINICAL EPIGENETICS (2016)
Prevalence and Costs of Skin Cancer Treatment in the US, 2002-2006 and 2007-2011
Gery P. Guy et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2015)
Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
Cristina Fortes et al.
MELANOMA RESEARCH (2015)
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities
Jian Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy
Christopher N. Hahn et al.
IMMUNOLOGICAL REVIEWS (2015)
Cutaneous Malignant Melanoma: Update on Diagnostic and Prognostic Biomarkers
Ossama Abbas et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2014)
A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets
Sophia Adamia et al.
CLINICAL CANCER RESEARCH (2014)
PKM2: The Thread Linking Energy Metabolism Reprogramming with Epigenetics in Cancer
Ling Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
A Pan-Cancer Analysis of Transcriptome Changes Associated with Somatic Mutations in U2AF1 Reveals Commonly Altered Splicing Events
Angela N. Brooks et al.
PLOS ONE (2014)
Splicing mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer
Stephanie N. Dorman et al.
SCIENTIFIC REPORTS (2014)
The RNA-Binding Protein QKI Suppresses Cancer-Associated Aberrant Splicing
Feng-Yang Zong et al.
PLOS GENETICS (2014)
S-100B: A Stronger Prognostic Biomarker than LDH in Stage IIIB-C Melanoma
K. P. Wevers et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Regulation of microRNAs by epigenetics and their interplay involved in cancer
Xiaolan Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Correlation among metallothionein expression, intratumoural macrophage infiltration and the risk of metastasis in human cutaneous malignant melanoma
E. Emri et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Acquired Mutations That Affect Pre-mRNA Splicing in Hematologic Malignancies and Solid Tumors
Linda M. Scott et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Prognostic Value of BRAF V600 Mutations in Melanoma Patients After Resection of Metastatic Lymph Nodes
Stephanie Moreau et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis
B. Weide et al.
BRITISH JOURNAL OF CANCER (2012)
NRAS mutation status is an independent prognostic factor in metastatic melanoma
John A. Jakob et al.
CANCER (2012)
Histological ulceration as a prognostic factor in cutaneous melanoma: a study of 423 cases in Spain
Jose Antonio Aviles-Izquierdo et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma
Friederike Egberts et al.
EUROPEAN JOURNAL OF CANCER (2012)
Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma
Sarah J. Storr et al.
MODERN PATHOLOGY (2012)
The Prognostic Value of BRAF Mutation in Colorectal Cancer and Melanoma: A Systematic Review and Meta-Analysis
Gholamreza Safaee Ardekani et al.
PLOS ONE (2012)
The Caenorhabditis elegans Gene mfap-1 Encodes a Nuclear Protein That Affects Alternative Splicing
Long Ma et al.
PLOS GENETICS (2012)
RBPDB: a database of RNA-binding specificities
Kate B. Cook et al.
NUCLEIC ACIDS RESEARCH (2011)
KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
Chen Xie et al.
NUCLEIC ACIDS RESEARCH (2011)
Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
Jozsef Timar et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Expansion of the eukaryotic proteome by alternative splicing
Timothy W. Nilsen et al.
NATURE (2010)
Aberrant DNA methylation in malignant melanoma
Carolina Schinke et al.
MELANOMA RESEARCH (2010)
Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
A-Yong Cao et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
A-Yong Cao et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
Mohammed Kashani-Sabet et al.
CLINICAL CANCER RESEARCH (2009)
Melanoma Prognostic Model Using Tissue Microarrays and Genetic Algorithms
Bonnie E. Gould Rothberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival
Fredrik Petersson et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2009)
RNA-binding proteins and post-transcriptional gene regulation
Tina Glisovic et al.
FEBS LETTERS (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
Qun Pan et al.
NATURE GENETICS (2008)
RNA-binding proteins: modular design for efficient function
Bradley M. Lunde et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Metallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients
G Weinlich et al.
BRITISH JOURNAL OF CANCER (2006)
Calculation of survival of patients with stage III melanoma
D Berd et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements
IG Bruno et al.
HUMAN MOLECULAR GENETICS (2004)
Prognostic immunohistochemical markers of primary human melanomas
H Ostmeier et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
分享论文
